Bruce & Co., Inc. — 13F Holdings & Portfolio
CIK 1358331 · latest 13F-HR filed 2026-08-14
Bruce & Co., Inc. manages $369.5M in 13F-reported U.S. long-equity assets across 41 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are ABBV (8.24%), ALL (7.89%), AER (7.30%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 0 new positions and exited 0; 21 existing positions rose in reported value and 13 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-08-14
vs 2026-03-31
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q2 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q1 26 → Q2 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
4 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 60.6%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Mar 26, 2026.
CHICAGO, IL 60606
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| BRUCE, ROBERT, JEFFREY Control | PRESIDENT, CHIEF COMPLIANCE OFFICER since Jun 2023 | 75% or more | Individual |
Ownership & leadership changes · 3 filings with changes since Apr 3, 2012
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedBRUCE, ROBERT, B · PRESIDENT · Less than 5% · control person · listed since Aug 1974
- ChangedBRUCE, ROBERT, JEFFREY · title SECRETARY, CHIEF COMPLIANCE OFFICER → PRESIDENT, CHIEF COMPLIANCE OFFICER
- ChangedBRUCE, ROBERT, B · ownership 50–75% → Less than 5%
- ChangedBRUCE, ROBERT, JEFFREY · ownership 25–50% → 75% or more
- ChangedBRUCE, ROBERT, B · title PRESIDENT, CHIEF COMPLIANCE OFFICER → PRESIDENT
- ChangedBRUCE, ROBERT, JEFFREY · title SECRETARY → SECRETARY, CHIEF COMPLIANCE OFFICER
- ListedBRUCE, ROBERT, B · PRESIDENT, CHIEF COMPLIANCE OFFICER · 50–75% · control person
- ListedBRUCE, ROBERT, JEFFREY · SECRETARY · 25–50% · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Adds (vs prior quarter)
- Vicor$7.8M +74.2%
- Beta Bionics$4.9M +89.0%
- Uhaul B$3.9M +19.2%
- Abbvie$3.8M +14.3%
- Allstate$3.5M +13.7%
Top Trims
- AT & T-$4.4M -29.3%
- Nextera Energy-$2.1M -7.4%
- Lyondellbasell-$1.7M -34.6%
- Abbott-$1.5M -12.8%
- Newmont-$1.5M -13.7%
Bruce & Co., Inc. Holdings (2026-06-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | Abbvie | ABBV | 00287Y109 | $30.4M | 8.24% | 121,000 | SH |
| 2 | Allstate | ALL | 020002101 | $29.1M | 7.89% | 122,500 | SH |
| 3 | AerCap Holdings | AER | N00985106 | $27.0M | 7.30% | 185,000 | SH |
| 4 | Nextera Energy | NEE | 302571104 | $25.8M | 6.99% | 294,300 | SH |
| 5 | Merck | MRK | 589331107 | $24.5M | 6.64% | 190,800 | SH |
| 6 | Uhaul B | UHAL.B | 023586506 | $24.1M | 6.51% | 417,000 | SH |
| 7 | Duke Energy | DUK | 26441C204 | $18.3M | 4.96% | 144,816 | SH |
| 8 | Vicor | VICR | 925815102 | $18.2M | 4.93% | 48,000 | SH |
| 9 | XCEL Energy | XEL | 98389B100 | $14.7M | 3.97% | 182,500 | SH |
| 10 | CMS Energy | CMS | 125896100 | $11.7M | 3.17% | 153,000 | SH |
| 11 | AT & T | T | 00206R102 | $10.7M | 2.90% | 518,000 | SH |
| 12 | Apple | AAPL | 037833100 | $10.7M | 2.89% | 36,900 | SH |
| 13 | Beta Bionics | BBNX | 08659B102 | $10.4M | 2.82% | 665,700 | SH |
| 14 | Insteel | IIIN | 45774W108 | $10.4M | 2.81% | 343,423 | SH |
| 15 | Abbott | ABT | 002824100 | $10.2M | 2.76% | 112,300 | SH |
| 16 | Newmont | NEM | 651639106 | $9.3M | 2.53% | 100,000 | SH |
| 17 | Avista | AVA | 05379B107 | $8.2M | 2.21% | 200,000 | SH |
| 18 | Archer Daniels | ADM | 039483102 | $7.6M | 2.07% | 100,000 | SH |
| 19 | Bunge | BG | H11356104 | $7.5M | 2.02% | 70,000 | SH |
| 20 | Supernus | SUPN | 868459108 | $7.0M | 1.89% | 150,000 | SH |
| 21 | Pfizer | PFE | 717081103 | $6.5M | 1.75% | 268,200 | SH |
| 22 | Darling Ingredients | DAR | 237266101 | $5.7M | 1.55% | 105,000 | SH |
| 23 | Kodiak Sciences | KOD | 50015M109 | $5.6M | 1.53% | 145,000 | SH |
| 24 | Chemours | CC | 163851108 | $5.1M | 1.39% | 250,000 | SH |
| 25 | Uhaul | UHAL | 023586100 | $4.8M | 1.29% | 72,600 | SH |
| 26 | Lyondellbasell | LYB | N53745100 | $3.2M | 0.85% | 60,000 | SH |
| 27 | Personalis | PSNL | 71535D106 | $3.1M | 0.84% | 233,000 | SH |
| 28 | Fate Theraputics | FATE | 31189P102 | $2.7M | 0.72% | 989,188 | SH |
| 29 | Eli Lilly | LLY | 532457108 | $2.4M | 0.65% | 2,000 | SH |
| 30 | RLI | RLI | 749607107 | $2.4M | 0.64% | 40,000 | SH |
| 31 | Apogee | APOG | 037598109 | $2.3M | 0.62% | 50,000 | SH |
| 32 | FocalTherics | FOCL | 268311107 | $2.3M | 0.61% | 438,652 | SH |
| 33 | XM Sirius | SIRI | 82968B103 | $1.6M | 0.45% | 55,784 | SH |
| 34 | Venture Global | VG | 92333F101 | $1.1M | 0.30% | 100,000 | SH |
| 35 | Ashland | ASH | 044209104 | $988.4K | 0.27% | 15,000 | SH |
| 36 | Viatris | VTRS | 92556V106 | $916.2K | 0.25% | 57,696 | SH |
| 37 | Mannkind | MNKD | 56400P706 | $831.0K | 0.22% | 195,073 | SH |
| 38 | Bausch Health | BHC | 91911K102 | $611.3K | 0.17% | 124,000 | SH |
| 39 | 908 Devices | MASS | 65443P102 | $594.1K | 0.16% | 68,286 | SH |
| 40 | WEC Energy | WEC | 92939U106 | $460.7K | 0.12% | 3,945 | SH |
| 41 | Caribou Biosciences | CRBU | 142038108 | $440.0K | 0.12% | 250,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-06-30 | 2026-08-14 | $369.5M | 41 | 0001104659-26-096709 |
| 2026-03-31 | 2026-05-14 | $349.7M | 41 | 0001104659-26-061024 |
| 2025-12-31 | 2026-02-13 | $322.5M | 39 | 0001104659-26-015254 |
| 2025-09-30 | 2025-11-13 | $322.9M | 39 | 0001104659-25-111225 |
SUITE 2414
CHICAGO, IL 60606